Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study

Christina Ellervik1, Anne Tybjaerg-Hansen, Peer Grande

  • 1Department of Clinical Biochemistry, Herlev University Hospital, Herlev, Denmark.

Circulation
|July 7, 2005
PubMed

Insights

Hereditary hemochromatosis genotypes C282Y/C282Y, C282Y/H63D, and C282Y/wild-type were not linked to increased risk of ischemic heart disease (IHD) or myocardial infarction (MI). However, the study couldn't rule out a modest risk increase for some genotypes.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Public Health

Background:

  • Hereditary hemochromatosis is a genetic disorder.
  • Specific genotypes (C282Y/C282Y, C282Y/H63D, C282Y/wild-type) are associated with iron overload.
  • The link between these genotypes and ischemic heart disease (IHD) or myocardial infarction (MI) requires investigation.

Purpose of the Study:

  • To test the hypothesis that hereditary hemochromatosis genotypes are risk factors for IHD and MI.
  • To evaluate the association between C282Y/C282Y, C282Y/H63D, and C282Y/wild-type genotypes and the risk of IHD and MI.

Main Methods:

  • A prospective study of 9178 Danish individuals followed for 24 years.
  • A case-control study involving 2441 IHD and 1113 MI cases versus 8080 controls.
  • Statistical analysis to determine hazard ratios and odds ratios for IHD and MI associated with specific genotypes.

Main Results:

  • No significant association was found between C282Y/C282Y, C282Y/H63D, or C282Y/wild-type genotypes and increased risk of IHD or MI in prospective studies.
  • Case-control studies also revealed no association between these genotypes and increased risk of IHD or MI.
  • The study had 90% power to detect hazard ratios of 3.4 for C282Y/C282Y and 1.9 for C282Y/H63D.

Conclusions:

  • Hereditary hemochromatosis genotypes C282Y/C282Y, C282Y/H63D, and C282Y/wild-type are not associated with IHD or MI in this population.
  • The study lacked sufficient power to exclude a modest increased risk of IHD or MI for C282Y/C282Y and C282Y/H63D genotypes.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...